Related Experiment Videos
Miscoding during DNA synthesis on damaged DNA templates catalysed by mammalian cell extracts
1Department of Pharmacological Sciences, State University of New York at Stony Brook 11794-8651.
Cancer Letters
|August 15, 1994
Summary
This study shows how damaged DNA, like 8-oxodG, 8-oxodA, and O6medG, is repaired in human and mouse cells. The findings help predict the mutagenic potential of DNA damage in mammals.
Area of Science:
- Molecular Biology
- Genetics
- Toxicology
Background:
- DNA damage can lead to mutations.
- Understanding DNA repair mechanisms is crucial for preventing diseases like cancer.
- Specific DNA lesions, such as 8-oxodG, 8-oxodA, and O6medG, are common and can arise from oxidative stress or alkylation.
Purpose of the Study:
- To investigate the mutagenic potential of specific DNA lesions (8-oxodG, 8-oxodA, O6medG) in mammalian DNA synthesis.
- To characterize the DNA synthesis fidelity opposite these lesions using cell extracts.
- To establish a model system for predicting DNA damage mutagenicity in mammalian cells.
Main Methods:
- Oligodeoxynucleotides containing site-specific DNA modifications (8-oxodG, 8-oxodA, O6medG) were synthesized.
- Primer-extension reactions were performed using cell extracts from HeLa, COS-7 cells, and mouse tissues.
- Reaction products were analyzed using two-phase polyacrylamide gel electrophoresis to determine nucleotide incorporation opposite the lesions.
Main Results:
- Human and simian cell extracts preferentially incorporated dAMP opposite 8-oxodG.
- dTMP was incorporated opposite 8-oxodA.
- dTMP and some dCMP were incorporated opposite O6medG.
- Translesional synthesis was inhibited by N-ethylmaleimide and N-butylphenyl-dGTP.
Conclusions:
- The study developed a model system to assess the mutagenic potential of specific DNA damages.
- The observed nucleotide incorporation patterns provide insights into the fidelity of DNA synthesis across these lesions.
- This model can predict the mutagenic outcomes of DNA damage in mammalian systems, aiding in risk assessment and therapeutic development.